Results 281 to 290 of about 809,966 (374)

Advances in individualization of systemic treatment for locoregionally advanced nasopharyngeal carcinoma: a systematic review. [PDF]

ESMO Open
Blanchard P, De Felice F, Chua MLK.
europepmc   +1 more source

Opportunities in Therapeutic mRNA Stabilization: Sequence, Structure, Adjuvants and Vectors

Advanced Therapeutics, EarlyView.
Current mRNA lipid nanoparticles rely on cold storage, which increases the cost and reduces access to the vaccines. As mRNA expands to other clinical opportunities, better methods to stabilize the medicines during shipping, storage, and delivery are needed.
Joshua A. Choe, Jacobus Burger, Jamie Jones, Apurva Panjla, William L. Murphy   +4 more
wiley   +1 more source

The level of estrogen receptor (ER) expression and the length of adjuvant hormonal therapy in ER positive breast cancer. [PDF]

Gland Surg
Stravodimou A, Voutsadakis IA.
europepmc   +1 more source

Prolongation of inflammation in rats inoculated with adjuvant.

, 1970
Yutaka Mizushima, Wataru Tsukada, Takayuki Akimoto   +2 more
openalex   +1 more source

Accelerated Bone Healing via Electrical Stimulation

Advanced Science, EarlyView.
Electrical stimulation significantly impacts bone healing by enhancing osteoblast proliferation, differentiation, and vascularization through calmodulin/calcineurin/NFAT signaling. It also boosts macrophage function and cell migration, presenting a comprehensive approach to accelerating bone repair.
Jianfeng Sun, Wenqing Xie, Yuxiang Wu, Zhou Li, Yusheng Li   +4 more
wiley   +1 more source

Early-Stage Renal Cell Carcinoma: Who Needs Adjuvant Therapy? [PDF]

Biomedicines
Parosanu AI, Nititpir C, Stanciu IM, Baston C.   +3 more
europepmc   +1 more source

Sustained Vaccine Exposure Elicits More Rapid, Consistent, and Broad Humoral Immune Responses to Multivalent Influenza Vaccines

Advanced Science, EarlyView.
This work presents an injectable polymer‐nanoparticle hydrogel depot platform for delivering multivalent influenza vaccines which induces stronger and more durable immune responses. The technology provides broader protection, including against heterologous and potential pandemic strains (H5N1, H7N9, H9N2), and enhances the effectiveness of commercial ...
Olivia M. Saouaf, Ben S. Ou, Ye Eun Song, Joshua J. Carter, Jerry Yan, Carolyn K. Jons, Christopher O. Barnes, Eric A. Appel   +7 more
wiley   +1 more source

Correction: Preferences of patients with high-risk HR+/HER2- breast cancer for adjuvant endocrine treatment: an adaptive choice-based conjoint analysis study from Germany. [PDF]

Breast Cancer Res Treat
Wöckel A, Park-Simon TW, Korfel A, Raab K, Tesch H.   +4 more
europepmc   +1 more source

PCSK9 Promotes the Malignancy of Triple‐negative Breast Cancer Cells by Reducing Cholesterol Levels at the Plasma Membrane to Activate EGFR and HER3

Advanced Science, EarlyView.
By decreasing cholesterol and lipid raft levels in the plasma membrane, proprotein convertase subtilisin/kexin type 9 (PCSK9) boosts human epidermal growth factor receptor 1 and 3 (EGFR and HER3) activation, driving tumor growth and metastasis in triple‐negative breast cancer (TNBC).
Tianhong Li, Renfei Wu, Kathy Qian Luo
wiley   +1 more source

Screening and exploration of neoadjuvant "de-escalation" therapy for early breast cancer. [PDF]

Front Pharmacol
Zhang N, Shan M, Huang Z, Gao F, Xu B, Kang W, Zhang J, Song L, Liu J, Zhang J, Liu M, Jiang H, Liu X, Shen Z, Zhang P, Nanding A, Zhang G.   +16 more
europepmc   +1 more source